Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Natura:	Articolo
Lingua:	English
Pubblicazione:	American Association for the Advancement of Science (AAAS) 2020-01-01
Serie:	Research
Accesso online:	http://dx.doi.org/10.34133/2020/1458090

Documenti analoghi

Ureteral stent technology: Drug-eluting stents and stent coatings
di: Luo Yang, et al.
Pubblicazione: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
di: Josep Gomez‐Lara, et al.
Pubblicazione: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
di: E. Y. Zagorulko, et al.
Pubblicazione: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
di: Yusuke Tsukada, et al.
Pubblicazione: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
di: Qing Ma, et al.
Pubblicazione: (2021-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
di: Hang Ouyang, et al.
Pubblicazione: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
di: Jing Wang, et al.
Pubblicazione: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
di: Walid Maamoun
Pubblicazione: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
di: А. Н. Кудряшов, et al.
Pubblicazione: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
di: Paweł Gąsior, et al.
Pubblicazione: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
di: Yang O, et al.
Pubblicazione: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
di: Juntao Yin, et al.
Pubblicazione: (2023-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
di: Yi-Xing Yang, et al.
Pubblicazione: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
di: I. Rykowska, et al.
Pubblicazione: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
di: Hongxia Li, et al.
Pubblicazione: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
di: Michał Hawranek, et al.
Pubblicazione: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
di: Zhu, Xiaoxiang, et al.
Pubblicazione: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
di: Masaki Hirose, et al.
Pubblicazione: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
di: Matthew G. Whitbeck, et al.
Pubblicazione: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
di: Ahmed Abdelaziz, et al.
Pubblicazione: (2024-11-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
di: Zoltán-István Szabó, et al.
Pubblicazione: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
di: Nina Peng, et al.
Pubblicazione: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
di: Ng, Anthony Herr Cheun
Pubblicazione: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
di: Maciej Koźlik, et al.
Pubblicazione: (2023-02-01)

Drug-eluting stents: long-term safety
di: Yu A Karpov, et al.
Pubblicazione: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
di: Imad Sheiban, et al.
Pubblicazione: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
di: Sohila Refahi, et al.
Pubblicazione: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
di: Xiao-Fang Tang, et al.
Pubblicazione: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
di: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Pubblicazione: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
di: Jonathan Hanna, et al.
Pubblicazione: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
di: Cheng-Hsuan Tsai, et al.
Pubblicazione: (2022-06-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
di: Ali S. Almasood, et al.
Pubblicazione: (2011-01-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
di: Yinping Zhao, et al.
Pubblicazione: (2021-02-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
di: Sacharias von Koch, et al.
Pubblicazione: (2024-12-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
di: Fong, Timothy Ren Zhong
Pubblicazione: (2015)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
di: Spadaccio Cristiano, et al.
Pubblicazione: (2016-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
di: Iraj Jafaripour, et al.
Pubblicazione: (2023-05-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
di: Porto, I, et al.
Pubblicazione: (2005)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
di: Yi-Xing Yang, et al.
Pubblicazione: (2023-01-01)

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon in Left Main Coronary Artery Disease
di: Rong-Xue Xiao, et al.
Pubblicazione: (2022-04-01)